StonvexLoading…
StonvexStonvexStonvexCore line items from URGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $109.79M | $90.40M | $65.83M | $40.63M |
Operating Income | $-124.86M | $-96.78M | Not available | Not available |
Net Income | $-153.49M | $-126.87M | $-89.36M | $-65.69M |
EPS (Diluted) | $-3.19 | $-2.96 | $-2.15 | $-1.69 |
Total Assets | $200.46M | $285.71M | Not available | Not available |
Total Liabilities | $305.93M | $294.51M | Not available | Not available |
Cash & Equivalents | $110.75M | $171.99M | Not available | Not available |
Free Cash Flow OCF − CapEx | $-162.73M | $-97.06M | Not available | Not available |
Shares Outstanding | 48.35M | 42.23M | 41.48M | 38.79M |